These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24184373)

  • 1. Carbon nanotubes as vectors for gene therapy: past achievements, present challenges and future goals.
    Bates K; Kostarelos K
    Adv Drug Deliv Rev; 2013 Dec; 65(15):2023-33. PubMed ID: 24184373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors.
    Singh R; Pantarotto D; McCarthy D; Chaloin O; Hoebeke J; Partidos CD; Briand JP; Prato M; Bianco A; Kostarelos K
    J Am Chem Soc; 2005 Mar; 127(12):4388-96. PubMed ID: 15783221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonviral vectors for the delivery of small interfering RNAs to the CNS.
    Posadas I; Guerra FJ; Ceña V
    Nanomedicine (Lond); 2010 Oct; 5(8):1219-36. PubMed ID: 21039199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of microorganisms as delivery vehicles in cancer gene therapies].
    Łepeta K; Łasica AM; Jagusztyn-Krynicka EK
    Postepy Biochem; 2012; 58(3):314-26. PubMed ID: 23373417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HVJ envelope vector, a versatile delivery system: its development, application, and perspectives.
    Zhang Q; Li Y; Shi Y; Zhang Y
    Biochem Biophys Res Commun; 2008 Aug; 373(3):345-9. PubMed ID: 18588856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivatized Carbon Nanotubes for Gene Therapy in Mammalian and Plant Cells.
    Singh A; Hua Hsu M; Gupta N; Khanra P; Kumar P; Prakash Verma V; Kapoor M
    Chempluschem; 2020 Mar; 85(3):466-475. PubMed ID: 32159284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Delivery with Organic Electronic Biomaterials.
    Clancy KFA; Hardy JG
    Curr Pharm Des; 2017; 23(24):3614-3625. PubMed ID: 28699530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling the kinetics of interferon transgene expression for improved gene therapy.
    Watcharanurak K; Nishikawa M; Takahashi Y; Takakura Y
    J Drug Target; 2012 Nov; 20(9):764-9. PubMed ID: 22994266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy and DNA delivery systems.
    Ibraheem D; Elaissari A; Fessi H
    Int J Pharm; 2014 Jan; 459(1-2):70-83. PubMed ID: 24286924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA and carbon nanotubes as medicine.
    Cheung W; Pontoriero F; Taratula O; Chen AM; He H
    Adv Drug Deliv Rev; 2010 Apr; 62(6):633-49. PubMed ID: 20338203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatin-based delivery systems for cancer gene therapy.
    Nezhadi SH; Choong PF; Lotfipour F; Dass CR
    J Drug Target; 2009 Dec; 17(10):731-8. PubMed ID: 19863194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-guided gene delivery.
    Martin ME; Rice KG
    AAPS J; 2007 Feb; 9(1):E18-29. PubMed ID: 17408236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of carbon nanotubes for gene delivery vectors.
    Ramos-Perez V; Cifuentes A; Coronas N; de Pablo A; Borrós S
    Methods Mol Biol; 2013; 1025():261-8. PubMed ID: 23918344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transposon-based vector systems for gene therapy clinical trials: challenges and considerations.
    Meir YJ; Wu SC
    Chang Gung Med J; 2011; 34(6):565-79. PubMed ID: 22196059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of hybrid viral vectors for gene therapy.
    Huang S; Kamihira M
    Biotechnol Adv; 2013; 31(2):208-23. PubMed ID: 23070017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendrimers for gene delivery--a potential approach for ocular therapy?
    Chaplot SP; Rupenthal ID
    J Pharm Pharmacol; 2014 Apr; 66(4):542-56. PubMed ID: 24635556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-circulating vectors for the systemic delivery of genes.
    Fenske DB; MacLachlan I; Cullis PR
    Curr Opin Mol Ther; 2001 Apr; 3(2):153-8. PubMed ID: 11338928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer technology in therapy: current applications and future goals.
    Romano G; Pacilio C; Giordano A
    Stem Cells; 1999; 17(4):191-202. PubMed ID: 10437982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled delivery of antisense oligonucleotides: a brief review of current strategies.
    Zhao X; Pan F; Holt CM; Lewis AL; Lu JR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):673-86. PubMed ID: 19552611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative approaches for enhancing cancer gene therapy.
    Bhatia S; Menezes ME; Das SK; Emdad L; Dasgupta S; Wang XY; Sarkar D; Fisher PB
    Discov Med; 2013 May; 15(84):309-17. PubMed ID: 23725604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.